Literature DB >> 21747631

Morphea developing at the site of healed herpes zoster.

Tae Woo Noh1, Sang Hoon Park, Yoo Seok Kang, Un Ha Lee, Hyun Su Park, Sang Jai Jang.   

Abstract

Wolf's isotopic response describes the occurrence of a new, unrelated disease that appears at the same location as a previously healed skin disease, and the most common primary skin disease of this phenomenon is herpes zoster. Several cutaneous lesions have been described to occur at the site of healed herpes zoster, and granulomatous dermatitis and granuloma annulare have been reported to be the most common second diseases. The pathogenesis of the isotopic response is still unclear. Morphea can develop at the site of regressed herpes zoster and a few such cases have been reported. We present here an additional case of morphea that developed at the site of previously healed herpes zoster, and we review the relevant literature.

Entities:  

Keywords:  Herpes zoster; Morphea; Scleroderma; Wolf's isotopic response

Year:  2011        PMID: 21747631      PMCID: PMC3130875          DOI: 10.5021/ad.2011.23.2.242

Source DB:  PubMed          Journal:  Ann Dermatol        ISSN: 1013-9087            Impact factor:   1.444


  23 in total

1.  Low-dose broad-band UVA in morphea using a new method for evaluation.

Authors:  M El-Mofty; H Zaher; M Bosseila; R Yousef; B Saad
Journal:  Photodermatol Photoimmunol Photomed       Date:  2000-04       Impact factor: 3.135

Review 2.  Tumor necrosis factor: a master-regulator of leukocyte movement.

Authors:  J D Sedgwick; D S Riminton; J G Cyster; H Körner
Journal:  Immunol Today       Date:  2000-03

Review 3.  Isotopic response after herpesvirus infection: an update.

Authors:  Vincenzo Ruocco; Eleonora Ruocco; Ilaria Ghersetich; Beatrice Bianchi; Torello Lotti
Journal:  J Am Acad Dermatol       Date:  2002-01       Impact factor: 11.527

4.  [ZOSTER AS A PREMORBID STATE OF A CIRCUMSCRIBED SCLERODERMA].

Authors:  H ZIMMERMANN
Journal:  Dermatol Wochenschr       Date:  1964-08-01

5.  PUVA-cream photochemotherapy for the treatment of localized scleroderma.

Authors:  M Grundmann-Kollmann; F Ochsendorf; T M Zollner; K Spieth; E Sachsenberg-Studer; R Kaufmann; M Podda
Journal:  J Am Acad Dermatol       Date:  2000-10       Impact factor: 11.527

6.  Treatment of linear scleroderma with oral 1,25-dihydroxyvitamin D3 (calcitriol) in seven children.

Authors:  E F Elst; L W Van Suijlekom-Smit; A P Oranje
Journal:  Pediatr Dermatol       Date:  1999 Jan-Feb       Impact factor: 1.588

7.  Different low doses of broad-band UVA in the treatment of morphea and systemic sclerosis.

Authors:  M El-Mofty; W Mostafa; M El-Darouty; M Bosseila; H Nada; R Yousef; S Esmat; M El-Lawindy; M Assaf; G El-Enani
Journal:  Photodermatol Photoimmunol Photomed       Date:  2004-06       Impact factor: 3.135

8.  Varicella-zoster virus DNA in granulomatous skin lesions following herpes zoster. A study by the polymerase chain reaction.

Authors:  U Serfling; N S Penneys; W Y Zhu; M Sisto; C Leonardi
Journal:  J Cutan Pathol       Date:  1993-02       Impact factor: 1.587

Review 9.  Isotopic response.

Authors:  R Wolf; S Brenner; V Ruocco; F G Filioli
Journal:  Int J Dermatol       Date:  1995-05       Impact factor: 2.736

Review 10.  Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cells.

Authors:  G Zurawski; J E de Vries
Journal:  Immunol Today       Date:  1994-01
View more
  4 in total

1.  A Case of Wolf's Isotopic Response Presenting as Bullous Pemphigoid.

Authors:  Seung Hyun Chun; Bo Young Kim; Chang Min Kim; Jae Beom Park; Hwa Jung Ryu
Journal:  Ann Dermatol       Date:  2017-06-21       Impact factor: 1.444

2.  Wolf's isotopic response, presenting as lichen planus.

Authors:  Mariana Thomaz da Silva Queiroz; José Roberto Paes de Almeida; Ângelo Sementilli; Sandra Lopes Mattos e Dinato; Ney Romiti
Journal:  An Bras Dermatol       Date:  2015 May-Jun       Impact factor: 1.896

Review 3.  Looking back to move forward: a twenty-year audit of herpes zoster in Asia-Pacific.

Authors:  Liang-Kung Chen; Hidenori Arai; Liang-Yu Chen; Ming-Yueh Chou; Samsuridjal Djauzi; Birong Dong; Taro Kojima; Ki Tae Kwon; Hoe Nam Leong; Edward M F Leung; Chih-Kuang Liang; Xiaohong Liu; Dilip Mathai; Jiun Yit Pan; Li-Ning Peng; Eduardo Rommel S Poblete; Philip J H Poi; Stewart Reid; Terapong Tantawichien; Chang Won Won
Journal:  BMC Infect Dis       Date:  2017-03-15       Impact factor: 3.090

4.  Wolf's Isotopic Response: Report of a Case and Review of Literature.

Authors:  Rahul Mahajan; Dipankar De; Uma Nahar Saikia
Journal:  Indian J Dermatol       Date:  2014-05       Impact factor: 1.494

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.